Blood-Based Extracellular Matrix Biomarkers Are Correlated With Clinical Outcome After PD-1 Inhibition in Patients With Metastatic Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood-Based Extracellular Matrix Biomarkers Are Correlated With Clinical Outcome After PD-1 Inhibition in Patients With Metastatic Melanoma
J Immunother Cancer 2020 Oct 01;8(2)e001193, DP Hurkmans, C Jensen, SLW Koolen, J Aerts, MA Karsdal, RHJ Mathijssen, N WillumsenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.